ICER flags +51% net launch prices, Novo board shake-up, Tecentriq’s ctDNA-guided bladder success, Exelixis OS bump in colorectal cancer, and Ideaya eye-saving data (Oct 17-23, 2025).
Hey, great read as always! You always manage to make these complex topics so clear and insightful. Totally agree with your take on the mRNA platfom's potential.
Hey, great read as always! You always manage to make these complex topics so clear and insightful. Totally agree with your take on the mRNA platfom's potential.
Thanks so much! I really appreciate the kind words :)